Claudia Ferrara Koller

10 Patents

• US125901512026

  Anti-human CD19 Antibodies with High Affinity

  Hoffmann-la Roche Inc.

  0 cites
• US125655302026

  Combination Therapy with Targeted 4-1BB (CD137) Agonists/anti-fap Binding Domain and Anti-cea/anti-cd3 Bispecific Antibody

  Hoffmann-la Roche Inc.

  0 cites
• US124418122025

  Methods of Treating Cancer by Administering Tumor Necrosis Factor (TNF) Family Ligand Trimer-containing Antigen-binding Molecules

  Hoffmann-la Roche Inc.

  0 cites
• US122811532025

  Combination Therapy with Targeted 4-1BB (CD137) Agonists

  Hoffmann-la Roche Inc.

  0 cites
• US122409112025

  Bispecific Antibodies Specific for OX40

  Hoffmann-la Roche Inc.

  0 cites
• US122275942025

  Bispecific 2+1 Contorsbodies

  Hoffmann-la Roche Inc.

  0 cites
• US122151522025

  Humanized Anti-human CD19 Antibodies and Methods of Use

  Hoffmann-la Roche Inc.

  0 cites
• US122028702025

  Antigen Binding Molecules Comprising a Trimeric TNF Family Ligand and Encoding Polynucleotides Thereof

  Hoffmann-la Roche Inc.

  0 cites
• US120654782024

  Her2-targeting Antigen Binding Molecules Comprising 4-1BBL

  Hoffmann-la Roche Inc.

  0 cites
• US117186802023

  Combination Therapy of Anti-cd20/anti-cd3 Bispecific Antibodies and 4-1BB (CD137) Agonists

  Hoffmann-la Roche Inc.

  0 cites